BridgeMD
New treatment option for Neoplasms
Official title Beyond TME Origins
ClinicalTrials.gov ID: NCT02292641
What this study is testing
- What it's testing
- All patients with recurrent colorectal cancer in the pelvis are eligible. The original primary tumour staging scans and resected surgical specimen needs to be available.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 and older
You may be able to join if
- Had a primary colorectal adenocarcinoma proven by biopsy taken as part of routine clinical practice
- Has a confirmed diagnosis of recurrent pelvic colorectal cancer
- Has previously completed surgical treatment of primary adenocarcinoma of the colon, sigmoid colon or rectum
- Are able to undergo high resolution MRI for staging prior to treatment decisions
- Have provided written informed consent to participate in the study
You likely can't join if
- Have irresectable extra-pelvic metastatic disease
- Original baseline staging and preoperative restaging scans (MR for rectal and sigmoid cancers and/or CT for colon and sigmoid cancers) are unavailable
- Original preoperative, surgical and adjuvant treatment has not been documented or is unavailable
See the full eligibility criteria
- Had a primary colorectal adenocarcinoma proven by biopsy taken as part of routine clinical practice
- Has a confirmed diagnosis of recurrent pelvic colorectal cancer
- Has previously completed surgical treatment of primary adenocarcinoma of the colon, sigmoid colon or rectum
- Are able to undergo high resolution MRI for staging prior to treatment decisions
- Have provided written informed consent to participate in the study
- Be aged 16 years or over
- Have irresectable extra-pelvic metastatic disease
- Original baseline staging and preoperative restaging scans (MR for rectal and sigmoid cancers and/or CT for colon and sigmoid cancers) are unavailable
- Original preoperative, surgical and adjuvant treatment has not been documented or is unavailable
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Norway
- Harrow, London, United Kingdom
- Oxford, Oxfordshire, United Kingdom
- Sutton, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Norway; Harrow, London, United Kingdom; Oxford, Oxfordshire, United Kingdom; Sutton, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.